ClinicalTrials.Veeva

Menu

HeRO Vascular Access Device Post Market Procedural Survey Protocol (PPS)

M

Merit Medical Systems

Status

Completed

Conditions

End Stage Renal Disease

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Post market observational survey of a vascular access device for access-challenged patients. Data collection efforts focused on patient medical and access history and implant procedure results.

Full description

Evaluation Design: This is a multi-center post market observational survey designed to collect procedural data on a minimum of 50 HeRO™ patients in the commercialization phase. Data will be collected retrospectively for patients already implanted with the HeRO™ device in the commercialization phase or prospectively for patients that receive the HeRO™ Device during the data collection period. No special patient screening, testing, or procedures are required. There is no required patient follow-up.

Subject Population: Any patients the investigator deems/deemed eligible for HeRO™ implant with complete procedural data are eligible for inclusion in this post market observational survey.

Endpoints: None

Inclusion/Exclusion Criteria: There are no formal screening criteria other than patients must have all required procedural data points available for recording on the case report form.

Enrollment

77 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • None

Exclusion criteria

  • None

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems